Apalutamide + abiraterone + leuprolide with stereotactic, ultra-hypofractionated radiation (AASUR) in very high risk prostate cancer (PCa).

TPS5100Background: Radiotherapy and long course (18-28 months) androgen deprivation therapy (ADT) is a current standard of care in very high risk PCa; however, biochemical failure remains frequent....